Back to Search
Start Over
PSCK9 inhibitors (PCSK9i) (monoclonal antibodies and inclisiran) in clinical practice. 5 years' experience of London tertiary lipid centre.
- Source :
-
Atherosclerosis (00219150) . 2023 Supplement 1, Vol. 379, pS166-S166. 1p. - Publication Year :
- 2023
- Subjects :
- *MONOCLONAL antibodies
*LIPIDS
Subjects
Details
- Language :
- English
- ISSN :
- 00219150
- Volume :
- 379
- Database :
- Academic Search Index
- Journal :
- Atherosclerosis (00219150)
- Publication Type :
- Academic Journal
- Accession number :
- 170905579
- Full Text :
- https://doi.org/10.1016/j.atherosclerosis.2023.06.561